Knoxville Company Successfully Achieves Commercial Use of its Next-Generation Biomarker Generator

ABT Molecular Imaging, Inc., in Knoxville, TN, has successfully achieved the installation and clinical use of its next-generation Biomarker Generator by the Sveta Marina University Hospital in Bulgaria. ABT’s next-generation product integrates a compact accelerator and micro-chemistry with integrated quality control, for single-dose biomarker production...
Read More>>

ABT Molecular Imaging Raises $6 Million to Continue Growth of Biomarker Generator

River Cities Capital Funds led the Series C financing, with new investors Limestone Fund, LLC and Council & Enhanced Tennessee Fund, LLC participating. Intersouth Partners, the company's first institutional investor, also participated. Concurrent with the financing round, Rik Vandevenne of River Cities Capital Funds joined the ABT Board of Directors...
Read More>>

King Fahad Medical City to install “Dose on Demand” Biomarker Generator from ABT

Knoxville, TN, UNITED STATES, April 30, 2012 – King Fahad Medical City (KFMC), the largest medical complex in Saudi Arabia, will employ the latest technology for PET Radiopharmaceutical production”.Tom Welch, CEO of ABT Molecular Imaging, stated “KFMC is recognized as a technical innovator in the Middle East, and we are honored to be working with such a prestigious institution. The ABT solution provides KFMC the platform for advanced biomarker production, and enables expansion of both their PET clinical and research capabilities”. KFMC will be the premier reference site for the Biomarker Generator in the Middle East.
Read More>>

Professor Bengt Langstrom joins ABT Board of Directors

Knoxville, Tennessee, January 23, 2012 - ABT Molecular Imaging, Inc. a molecular imaging company and manufacturer of the “Dose on Demand” Biomarker Generator which provides researchers and clinicians access to PET biomarkers on demand, today announced the appointment of Professor Bengt Langstrom to its Board of Directors.
Read More>>

'First in Europe' Cancer Equipment Delivered to Newcastle

A cutting-edge piece of cancer treatment and research equipment purchased through a record £625,000 contribution from the Sir Bobby Robson Foundation is being installed this week in Newcastle upon Tyne. The ultra-compact ABT Molecular Imaging Biomarker Generator is only the second of its type in the world and the first in Europe and will help with the diagnosis and treatment of cancer and other serious diseases...
Read More>>

ABT ships first Biomarker Generator in Europe to Newcastle University

ABT Molecular Imaging, Inc. a molecular imaging company and manufacturer of the "Dose on Demand" Biomarker Generator which provides researchers and clinicians access to PET biomarkers on demand, shipped the first system...
Read More>>

ABT Molecular Imaging Names New Radiochemist and New Director of Technical Services

ABT Molecular Imaging, a medical imaging company and manufacturer of the "Dose on Demand" Biomarker Generator for unit dose production of biomarkers for Molecular Imaging, announced today that Dr. Atilio Anzellotti has joined the company as Senior Radio-chemist, and Mr. Steve Torres has joined the company as the Senior Director of Technical Services.
Read More>>

OU college pioneers biomarker generator

The OU College of Pharmacy will be the first institution in the world to install and use a biomarker generator for help in imaging and diagnosing diseases. A biomarker generator creates a radiation tag doctors can look for in scans of the body to identify substances, such as cancerous tumors or brain plaques associated with Alzheimer’s disease, said Vibhudutta Awasthi, College of Pharmacy researcher and professor.
POSTED BY Kathleen Evans/The Daily @ oudaily.com
Read More>>